Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Dermatitis ; 33(1): 62-69, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35029350

RESUMO

BACKGROUND: Shoe contact allergy can be difficult to diagnose and manage. OBJECTIVE: The aim of the study was to characterize demographics, clinical characteristics, patch test results, and occupational data for the North American Contact Dermatitis Group patients with shoe contact allergy. METHODS: This is a retrospective study of 33,661 patients, patch tested from 2005 to 2018, with a shoe source, foot as 1 of 3 sites of dermatitis, and final primary diagnosis of allergic contact dermatitis. RESULTS: Three hundred fifty-two patients met the inclusion criteria. They were more likely to be male (odds ratio = 3.36, confidence interval = 2.71-4.17) and less likely to be older than 40 years (odds ratio = 0.49, confidence interval = 0.40-0.61) compared with others with positive patch test reactions. The most common relevant North American Contact Dermatitis Group screening allergens were potassium dichromate (29.8%), p-tert-butylphenol formaldehyde resin (20.1%), thiuram mix (13.3%), mixed dialkyl thioureas (12.6%), and carba mix (12%). A total of 29.8% (105/352) had positive patch test reactions to supplemental allergens, and 12.2% (43/352) only had reactions to supplemental allergens. CONCLUSIONS: Shoe contact allergy was more common in younger and male patients. Potassium dichromate and p-tert-butylphenol formaldehyde resin were the top shoe allergens. Testing supplemental allergens, personal care products, and shoe components should be part of a comprehensive evaluation of suspected shoe contact allergy.


Assuntos
Alérgenos/efeitos adversos , Dermatite Alérgica de Contato/diagnóstico , Dermatoses do Pé/diagnóstico , Sapatos/efeitos adversos , Adulto , Corantes/efeitos adversos , Estudos Transversais , Dermatite Alérgica de Contato/etiologia , Feminino , Dermatoses do Pé/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , América do Norte , Testes do Emplastro/métodos , Resinas Sintéticas/efeitos adversos , Estudos Retrospectivos , Borracha/efeitos adversos , Adulto Jovem
2.
Trials ; 21(1): 876, 2020 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-33092653

RESUMO

OBJECTIVES: To investigates the effectiveness of curcumin-containing Nanomicelles as a therapeutic supplement in the treatment of patients with COVID-19 and its effect on immune responses balance changes following treatment. TRIAL DESIGN: This study is conducted as a prospective, placebo-controlled with parallel group, single-center randomized clinical trial on COVID-19 patients. PARTICIPANTS: Patients are selected from the COVID-19 ward of Shahid Mohammadi Hospital in Bandar Abbas, Iran. INCLUSION CRITERIA: 1. Real time PCR-approved positive COVID-19 test. 2. Both gender 3. Age between 18 and 75 years 4. Signing a written consent 5. Lack of participation in other clinical trials Exclusion criteria: 1. Pregnancy or lactation 2. Allergy to turmeric or curcumin 3. Smoking 4. Patient connected to the ventilator 5. SaO2 less than 90% or PaO2 less than 8 kPa 6. Having comorbidities (such as severe renal failure, Glomerular filtration rate less than 30 ml/min, liver failure, Congestive heart failure, or Chronic obstructive pulmonary disease) 7. History of gallstones 8. History of gastritis or active gastrointestinal ulcer INTERVENTION AND COMPARATOR: In addition to the routine standard treatments for COVID-19, in the intervention group, 40mg nanomicelles containing curcumin (SinaCurcumin Capsule, Exir Nano Sina Company, Iran), four times per day (after breakfast, lunch, dinner and before bedtime) and in the placebo group as the control group, capsules with the same appearance and characteristics (Placebo capsules, Exir Nano Sina Company, Iran) are prescribed for two weeks. MAIN OUTCOMES: The effectiveness of Nano micelles containing curcumin treatment will be evaluated as daily clinical examinations of patients in both groups and, on days 0, 7 and 14, complete clinical symptoms and laboratory findings including peripheral blood and serum parameters such as inflammatory markers will be measured and recorded. Moreover, in order to evaluate the balance of immune responses changes following treatments, serum level of IFN-γ, IL-17, Il-4 and TGF-ß serum cytokines will be measured in both groups at time points of 0, 7 and 14 days post treatment. Gene expression of t-bet, GATA-3, FoxP3 and ROR- γT will also be measured at mentioned time points to assess the shift of T helper1, T helper2, T regulatory and T helper 17 immune responses following treatment. RANDOMISATION: Randomized trials will be performed on 40 COVID-19 patients which will be randomized using encoded sealed boxes with computer generated random digits with 1:1 allocation ratio. In order to randomization, placebo and SinaCurcumin Capsules will be numbered first by computer generated random digits. SinaCurcumin and placebo will then be stored and numbered in sealed packages based on generated random numbers. Finally, according to the order in which patients enter the study, packages are given to patients based on their number. BLINDING (MASKING): The present study will be blind for all patients, physicians and nurses, laboratory technicians and statisticians. NUMBERS TO BE RANDOMISED (SAMPLE SIZE): A total of 40 patients will be included in the study, 20 of them will be randomly assigned to the intervention group and 20 to the placebo group. TRIAL STATUS: This is Version 1.0 of protocol dated 21 May 2020. The recruitment was started June 24, 2020 and is expected to be completed by October 31, 2020. TRIAL REGISTRATION: This present clinical trial has been registered in the Iranian Registry of Clinical Trials (IRCT) with the registration code of "IRCT20200611047735N1", https://www.irct.ir/trial/48843 . Dated: 19 June 2020. FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.


Assuntos
Betacoronavirus/efeitos dos fármacos , Corantes/uso terapêutico , Infecções por Coronavirus/tratamento farmacológico , Curcumina/uso terapêutico , Pneumonia Viral/tratamento farmacológico , Adolescente , Adulto , Idoso , Betacoronavirus/genética , Betacoronavirus/imunologia , Biomarcadores/metabolismo , COVID-19 , Estudos de Casos e Controles , Corantes/efeitos adversos , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/imunologia , Infecções por Coronavirus/virologia , Curcumina/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Feminino , Expressão Gênica/genética , Humanos , Interleucinas/imunologia , Irã (Geográfico)/epidemiologia , Masculino , Micelas , Pessoa de Meia-Idade , Pandemias , Placebos/administração & dosagem , Pneumonia Viral/epidemiologia , Pneumonia Viral/imunologia , Pneumonia Viral/virologia , Estudos Prospectivos , SARS-CoV-2 , Resultado do Tratamento , Adulto Jovem
3.
Medicine (Baltimore) ; 99(43): e22916, 2020 Oct 23.
Artigo em Inglês | MEDLINE | ID: mdl-33120843

RESUMO

BACKGROUND: Inflammatory bowel diseases (IBD), which include Crohn disease and ulcerative colitis, affect several million individuals worldwide. Curcumin as a complementary therapy has been used to cure the IBD, yet the efficacy and safety of curcumin remains to be assessed. In this study, we aim to draw up a protocol for systematic review to evaluate the efficacy and safety of curcumin for IBD. METHODS: We will search the following electronic databases from inception to September 31, 2020: PubMed, Cochrane Library, EMBASE, Web of Science, Medline, the China National Knowledge Infrastructure Database, Wan Fang Database, the Chinese Scientific Journal Database, and Chinese Biomedical Literature Database. Clinical trial registrations, potential gray literatures, relevant conference abstracts and reference list of identified studies will also be searched. Relevant randomized controlled clinical trials were enrolled and analyzed. The literature selection, data extraction, and quality assessment will be completed by 2 independent authors. Either the fixed-effects or random-effects model will be used for data synthesis based on the heterogeneity test. Clinical remission will be evaluated as the primary outcome. Clinical response, endoscopic remission, inflammatory markers and adverse events will be assessed as the secondary outcomes. The RevManV.5.3.5 will be used for Meta-analysis. Subgroup analyses of doses, delivery way, frequency of treatment and the degree of IBD severity or different forms of IBD were also conducted. RESULTS: This study will provide a synthesis of current evidence of curcumin for IBD from several aspects, such as clinical remission, clinical response, endoscopic remission, inflammatory markers, and adverse events. CONCLUSION: The conclusion of our study will provide updated evidence to judge whether curcumin is an effective solution to IBD patients. INPLASY REGISTRATION NUMBER: INPLASY202090065.


Assuntos
Corantes/uso terapêutico , Terapias Complementares/métodos , Curcumina/uso terapêutico , Doenças Inflamatórias Intestinais/terapia , China/epidemiologia , Colite Ulcerativa/terapia , Corantes/efeitos adversos , Doença de Crohn/terapia , Curcumina/efeitos adversos , Gerenciamento de Dados , Feminino , Humanos , Masculino , Avaliação de Resultados em Cuidados de Saúde , Ensaios Clínicos Controlados Aleatórios como Assunto , Segurança , Resultado do Tratamento , Metanálise como Assunto
5.
J Vasc Interv Radiol ; 30(3): 446-452, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30819492

RESUMO

PURPOSE: To evaluate the safety and efficacy of a mixture of indigo carmine and lipiodol (MIL) as a marker of pulmonary nodule before video-assisted thoracic surgery (VATS). MATERIALS AND METHODS: One hundred sixty-eight sessions of pulmonary marking were performed using MIL before VATS for 184 nodules (mean size, 1.2 ± 0.6 cm; range, 0.3-3.6 cm) on 157 patients (83 men and 74 women; median age, 66 years). The mean distance between the lung surface and the nodule was 0.8 ± 0.7 cm (range, 0-3.9 cm). MIL was injected near the nodule using a 23-gauge needle. Mean number of 1.2 ± 0.4 (range, 1-3) punctures were performed in a session for the target nodules, with mean number of 1.1 ± 0.3 (range, 1-3). Successful targeting, localization, and VATS were defined as achievement of lipiodol accumulation at the target site on computed tomography, detection of the nodule in the operative field by fluoroscopy or visualization of dye pigmentation, and complete resection of the target nodule with sufficient margin, respectively. RESULTS: The successful targeting rate was 100%, and the successful localization rate was 99.5%, with dye pigmentation for 160 nodules (87.0%) and intraoperative fluoroscopy for 23 nodules (12.5%). Successful VATS was achieved for 181 nodules (98.4%). Two nodules (1.1%) were not resectable, and surgical margin was positive in 1 nodule (0.5%). Complications requiring interventions occurred in 5 sessions (3.0%) and included pneumothorax with chest tube placement (n = 3) and aspiration (n = 2). No complication related to the injected MIL occurred. CONCLUSIONS: MIL was safe and useful for preoperative pulmonary nodule marking.


Assuntos
Corantes/administração & dosagem , Meios de Contraste/administração & dosagem , Óleo Etiodado/administração & dosagem , Índigo Carmim/administração & dosagem , Neoplasias Pulmonares/patologia , Nódulos Pulmonares Múltiplos/patologia , Cuidados Pré-Operatórios/métodos , Nódulo Pulmonar Solitário/patologia , Cirurgia Torácica Vídeoassistida , Adulto , Idoso , Idoso de 80 Anos ou mais , Corantes/efeitos adversos , Meios de Contraste/efeitos adversos , Óleo Etiodado/efeitos adversos , Feminino , Humanos , Índigo Carmim/efeitos adversos , Neoplasias Pulmonares/diagnóstico por imagem , Neoplasias Pulmonares/cirurgia , Masculino , Margens de Excisão , Pessoa de Meia-Idade , Nódulos Pulmonares Múltiplos/diagnóstico por imagem , Nódulos Pulmonares Múltiplos/cirurgia , Valor Preditivo dos Testes , Cuidados Pré-Operatórios/efeitos adversos , Estudos Retrospectivos , Fatores de Risco , Nódulo Pulmonar Solitário/diagnóstico por imagem , Nódulo Pulmonar Solitário/cirurgia , Tomografia Computadorizada por Raios X , Resultado do Tratamento
6.
J Insect Physiol ; 113: 1-8, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30582906

RESUMO

Several environmental factors (e.g. food source, pesticides, toxins, parasites and pathogens) influence development and maturation of honey bees (Apis mellifera). Therefore, controlled experimental conditions are mandatory when studying the impact of environmental factors: particularly food quality and nutrient consumption. In vitro larval rearing is a standard approach for monitoring food intake of larvae and the labelling of food is necessary to quantify intake in controlled feeding experiments. Here, we tested the suitability of two food dyes, Allura Red and Brilliant Blue, in an experimental set up using in vitro reared honey bee larvae and freshly hatched adult workers. Absorbance of both dyes was measured, in food and dye-fed larvae, to determine the optimal dye concentrations for accurate detection and quantification. By quantifying relative dye concentrations in dye mixtures, relative concentrations of mixed dyes can be estimated independent of the total food consumed by the larvae. Survival assays were conducted to test the impact of both dyes on larval and worker bee survival. Worker bees showed no increase in adult mortality, when fed with dyed honey. Larval survival was not significantly different until the late pupal stage. The physiological impact of dye feeding was tested by measuring larval immune response. No changes in innate immune gene expression were detectable for larvae fed with dyed and non-dyed food. In conclusion, we established a non-invasive food labelling protocol for food intake quantification in in vitro reared honey bee larvae, using non-toxic, inexpensive, and easy to apply food dyes.


Assuntos
Ração Animal/análise , Criação de Abelhas/métodos , Abelhas/fisiologia , Corantes/análise , Rotulagem de Alimentos , Animais , Compostos Azo/efeitos adversos , Compostos Azo/análise , Abelhas/crescimento & desenvolvimento , Benzenossulfonatos/efeitos adversos , Benzenossulfonatos/análise , Corantes/efeitos adversos , Dieta , Ingestão de Alimentos , Expressão Gênica/efeitos dos fármacos , Genes de Insetos/efeitos dos fármacos , Mel/análise , Imunidade Inata/efeitos dos fármacos , Larva/crescimento & desenvolvimento , Larva/fisiologia , Pupa/crescimento & desenvolvimento , Pupa/fisiologia
7.
Contact Dermatitis ; 77(6): 374-378, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28675523

RESUMO

BACKGROUND: Temporary tattoos made with an extract of the jagua fruit (Genipa americana L.) are becoming increasingly popular. It is claimed that it is 'dermatologically tested' and does not contain p-phenylenediamine. Extracts of jagua and gardenia fruits have been used by indigenous people in South America, as well as in traditional Chinese medicine, for centuries. Genipin is currently used for its cross-linking effect in the manufacture of polysaccharides, and is being investigated for its anti-inflammatory and other properties. OBJECTIVES: To report the presence of the allergenic substance genipin in a self-administered temporary tattoo dye made from the fruit juice of jagua (Genipa americana L.). PATIENTS AND METHODS: A 39-year-old female who repeatedly applied 'completely natural and 100% safe' Earth Jagua® tattoo, obtained via the internet, to her left hand developed allergic contact dermatitis within 6 weeks. Analysis of the dye showed the presence of geniposide and genipin. RESULTS: Patch tests with the dye and with its main components, including genipin, gave strong positive reactions to the latter. There was no sensitization to other ingredients or p-amino compounds. CONCLUSIONS: We report an extensively evaluated case of allergic contact dermatitis caused by a temporary Earth Jagua® tattoo. The allergen identified is genipin, a substance that is increasingly used for tattoos and as a therapeutic agent in medicine. This could result in an increase in the number of allergic reactions in the future.


Assuntos
Corantes/efeitos adversos , Dermatite Alérgica de Contato/etiologia , Iridoides/efeitos adversos , Tatuagem/efeitos adversos , Adulto , Dermatite Atópica/etiologia , Feminino , Humanos
10.
PLoS One ; 12(3): e0174736, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28358857

RESUMO

Indocyanine green (ICG) and brilliant blue G (BBG) are commonly used vital dyes to remove internal limiting membrane (ILM) in vitreoretinal surgery. The vital dyes have shown cytotoxic effects in ocular cells. Autophagy is a stress responsive pathway for either protecting cells or promoting cell death. However, the role of autophagy in ocular cells in response to the vital dyes remains unknown. In this study, we found that ICG and BBG reduced cell viability in both human retinal pigment epithelial ARPE-19 and mouse photoreceptor 661W cells. ICG and BBG induced lipidated GFP-LC3-II and LC3-II in ARPE-19 and 661W cells. Combination treatment with the autophagy inhibitor chloroquine indicated that ICG and BBG reduced autophagic flux in ARPE-19 cells, whereas the vital dyes induced autophagic flux in 661W cells. Moreover, genetic and pharmacological ablation of autophagy enhanced vital dyes-induced cytotoxicity in ocular cells. Dietary supplements, including resveratrol, lutein, and CoQ10, induced autophagy and diminished the cytotoxic effects of ICG and BBG in ocular cells. These results suggest that autophagy may protect ARPE-19 and 661W cells from vital dyes-induced damage.


Assuntos
Autofagia/efeitos dos fármacos , Corantes/efeitos adversos , Verde de Indocianina/efeitos adversos , Epitélio Pigmentado da Retina/efeitos dos fármacos , Corantes de Rosanilina/efeitos adversos , Animais , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Cloroquina , Humanos , Luteína/administração & dosagem , Camundongos , Substâncias Protetoras/administração & dosagem , Resveratrol , Epitélio Pigmentado da Retina/fisiopatologia , Epitélio Pigmentado da Retina/cirurgia , Estilbenos/administração & dosagem , Ubiquinona/administração & dosagem , Ubiquinona/análogos & derivados , Vitrectomia/efeitos adversos
11.
Curr Probl Dermatol ; 52: 94-104, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28288450

RESUMO

Tattooing has become very popular worldwide during the past decades, and millions of people have one or many tattoos at different anatomical sites. The color of tattoos is mainly black, followed by red, green, blue, and other colors. A part of the tattooed people regret tattooing or have permanent problems with tattoos and therefore seek for tattoo removal. Tattoos consist of solid pigment particles in the skin. Thus, tattoo removal requires fragmentation of these permanently incorporated particles. The gold standard of tattoo removal is laser therapy. Short light pulses at high intensities are applied to the tattooed skin surface. The laser light penetrates the skin and is selectively absorbed in the pigment particles. The absorbed laser light leads to heat-up and fragmentation of the particles. Due to the complex chemistry of the various tattoo pigments, the efficacy of this fragmentation process is frequently unpredictable. Due to the short and intense pulses, nonlinear effects of light and thermal properties of tattoo particles may play a role, and the assumptions of selective photothermolysis may not reflect the real process of tattoo particle fragmentation as a whole. In case fragmentation occurs, the concentration of pigment particles in the skin decreases, yielding a fading of the tattoo color in the skin. Laser therapy is most effective in black tattoos and less effective for colored tattoos. The rate of side effects is low due to the selectivity of the treatment. Laser light may change the chemistry of the tattoo pigments and hence provoke toxic decomposition products.


Assuntos
Terapia a Laser/métodos , Tatuagem/efeitos adversos , Cor , Corantes/efeitos adversos , Corantes/química , Procedimentos Cirúrgicos Dermatológicos/efeitos adversos , Procedimentos Cirúrgicos Dermatológicos/métodos , Alemanha , Humanos , Tinta , Terapia a Laser/efeitos adversos , Terapia com Luz de Baixa Intensidade/efeitos adversos , Terapia com Luz de Baixa Intensidade/métodos , Pele/lesões
12.
J Evid Based Complementary Altern Med ; 22(2): 232-236, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27103627

RESUMO

The color of urine is an important factor in urine examination, which can help physicians differentiate various diseases. Today, it is known that certain dyes, drug intoxications, and diseases can induce green urine discoloration. In the view of traditional Persian medicine, which is based on humoral medicine, green urine discoloration is generally referred to the dominance of coldness in the body. In fact, it is considered to be a result of a special kind of humoral imbalance and fluid depletion or retention in the human body. Persian scholars believed that green urine could be an indicator of intoxication or a predictor of an imminent spasm or convulsion in pediatric patients. Further investigations could result in finding new diagnostic scales of urine color based on the teachings of traditional Persian medicine.


Assuntos
Cor , Medicina Tradicional/métodos , Urinálise/métodos , Urina , Corantes/efeitos adversos , Diagnóstico Diferencial , Humanos , Irã (Geográfico) , Urina/química , Urina/fisiologia
13.
Int J Dermatol ; 55(12): 1345-1350, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27496199

RESUMO

BACKGROUND: The major causative agents in allergic contact dermatitis of the foot may differ from country to country. Sufficient data on foot eczema in patients from Turkey are lacking. OBJECTIVE: To identify the clinically relevant contact allergens in foot eczema and determine the role of patch test series and patients' own materials in the detection of the responsible allergens. METHODS: Among 1753 patients patch tested between 1996 and 2012 in our clinic, 53 with suspected allergic foot eczema were enrolled in this retrospective, cross-sectional study. Forty nine patients were patch tested with the extended European baseline series, 49 with supplemental series including rubber, leather, topical drugs, textile, cosmetic series containing preservatives and emulgators and varnish/plastic/glue series, and 37 with their own substances. RESULTS: Thirty of the 53 patch tested patients showing sensitization to at least one clinically relevant allergen were diagnosed with allergic foot eczema. The main eliciting agent was nitrofurazone (n = 8), followed by leather shoe allergens, ie, potassium dichromate (n = 6), p-tert-butylphenol formaldehyde resin and formaldehyde, in the second range. Rubber shoe allergens were less frequently observed (n = 3). In more than 1/3 of the patients, the causative agent could only be identified by testing the patient's own substances and/or supplemental series. CONCLUSION: Nitrofurazone was the leading causative agent followed by leather shoe allergens. Pediatric patients were frequently sensitized with shoe allergens. Patch testing with patient's own substances had a critical value in the detection of the causative agent in a significant number of patients.


Assuntos
Dermatite Alérgica de Contato/etiologia , Dermatoses do Pé/induzido quimicamente , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anti-Infecciosos/efeitos adversos , Criança , Pré-Escolar , Corantes/efeitos adversos , Estudos Transversais , Toxidermias/etiologia , Feminino , Formaldeído/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Nitrofurazona/efeitos adversos , Testes do Emplastro , Dicromato de Potássio/efeitos adversos , Resinas Sintéticas/efeitos adversos , Estudos Retrospectivos , Turquia , Adulto Jovem
14.
J Cosmet Laser Ther ; 18(2): 95-7, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26734817

RESUMO

A 64-year-old female presented with facial hyperpigmentation. She had dyed her hair monthly with pure henna powder for the past seven months. After patch tests, the patient was diagnosed as post-inflammatory hyperpigmentastion due to allergic contact dermatitis to pure henna that has rarely been reported. The patient underwent Q-switched Nd:YAG laser treatment and was treated with oral tranexamic acid for 10 weeks. The hyperpigmentation on her forehead demonstrated substantial improvement.


Assuntos
Antifibrinolíticos/uso terapêutico , Hiperpigmentação/radioterapia , Lasers de Estado Sólido/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Ácido Tranexâmico/uso terapêutico , Corantes/efeitos adversos , Terapia Combinada , Técnicas Cosméticas , Dermatite Alérgica de Contato/etiologia , Feminino , Tinturas para Cabelo/efeitos adversos , Humanos , Hiperpigmentação/etiologia , Pessoa de Meia-Idade , Naftoquinonas/efeitos adversos
15.
Clin Interv Aging ; 9: 1305-9, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25143716

RESUMO

Permanent makeup is a cosmetic tattoo that is used to enhance one's appearance, and which has become more popular among middle-aged and elderly women. A couple of benefits seem to be associated with permanent tattoos in the elderly: saving time (wake up with makeup); poor eyesight (difficult to apply makeup); and saving money. On the other hand, cosmetic tattoos bear the same risks as other tattoo procedures. We report on fading and unintended hyperpigmentation after tattooing on eyebrows and eyelids, and discuss the scientific and anatomical background behind the possible cause. Dermatochalasis may be a possible risk factor for excessive unwanted discolorations. Q-switched neodymium-doped yttrium aluminum garnet laser is an appropriate and safe therapeutic tool that can manage such adverse effects. Consumer protection warrants better information and education of the risks of cosmetic tattoos - in particular, for elderly women.


Assuntos
Corantes/efeitos adversos , Sobrancelhas , Pálpebras , Terapia com Luz de Baixa Intensidade/métodos , Tatuagem/efeitos adversos , Idoso , Alumínio , Feminino , Humanos , Pessoa de Meia-Idade , Fatores de Risco , Resultado do Tratamento , Ítrio
16.
J Ethnopharmacol ; 155(1): 80-103, 2014 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-24886774

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: The use of Lawsonia inermis L. (henna) for medicinal and cosmetic purposes is inextricably linked to ancient and modern cultures of North Africa and Asia. Literature and artwork indicates that Lawsonia inermis played an important holistic role in the daily lives of some ancient cultures, providing psychological and medicinal benefits, as well as being used for personal adornment. Although henna was historically applied to the hands and feet to protect against fungal pathogens and to hair to combat lice and dandruff, other traditional uses include the treatment of liver and digestive disorders, reduction of tissue loss in leprosy, diabetic foot disorders and ulcers. PHYTOCHEMISTRY: Almost 70 phenolic compounds have been isolated from various parts of the plant. Naphthaquinones, which include the dyeing principle lawsone, have been linked to many of the pharmacological activities. The terpene, ß-ionone is largely responsible for the pungent odour of the essential oil isolated from the flowers. In addition to other volatile terpenes, some non-volatile terpenoids, a single sterol, two alkaloids and two dioxin derivatives have also been isolated from the plant. BIOACTIVITY: Henna is a pharmacologically important plant with significant in vitro and in vivo biological activities. Although a myriad of pharmacological activities have been documented, the antioxidant and antimicrobial activities are the most thoroughly investigated. Some incidents of adverse reactions following application to the skin have been reported, but these are mainly confined to cases involving individuals with glucose-6-phosphate dehydrogenase deficiency and reactions to adulterants added to henna products. CONCLUSIONS: Adulteration of henna is very common and may have resulted in unwarranted scientific findings. Phytochemical profiling studies of the plant, which are crucial for the establishment of proper quality control protocols, are lacking and hamper the development of medicinal products. Although many in vitro studies have been conducted to evaluate the pharmacological activities and many in vivo studies have focussed on the toxicity of extracts, more in vivo studies to validate pharmacological activities are needed. The roles of specific compounds and their synergies have not been comprehensively investigated.


Assuntos
Lawsonia (Planta)/química , Naftoquinonas/farmacologia , Extratos Vegetais/farmacologia , Animais , Corantes/efeitos adversos , Corantes/isolamento & purificação , Corantes/farmacologia , Etnofarmacologia , Humanos , Medicina Tradicional/métodos , Naftoquinonas/efeitos adversos , Naftoquinonas/isolamento & purificação , Norisoprenoides/isolamento & purificação , Norisoprenoides/farmacologia , Extratos Vegetais/efeitos adversos , Extratos Vegetais/química
19.
Platelets ; 21(4): 297-9, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20196630

RESUMO

We report a case of total hyperpigmentation of the skin, severe itching, muscle weakness and thrombocytosis. Laboratory investigation showed white blood cell (WBC) 8.2 x 10(6)/L, Hb 125 g/L, platelets 1221 x 10(6)/L and urinary lead after DMSA mobilization test 2684 mcg/g creatinine (normal <5). Chelation therapy with DMSA resulted in complete recovery of the hyperpigmentation, itching and thrombocytosis. Lead poisoning should be considered in the differential diagnosis of obscured thrombocytosis.


Assuntos
Intoxicação por Chumbo/complicações , Trombocitose/etiologia , Quelantes/uso terapêutico , Terapia por Quelação , Doença Crônica , Corantes/efeitos adversos , Humanos , Intoxicação por Chumbo/tratamento farmacológico , Intoxicação por Chumbo/etiologia , Masculino , Pessoa de Meia-Idade , Succímero/uso terapêutico , Trombocitose/diagnóstico , Trombocitose/tratamento farmacológico
20.
Dermatitis ; 20(3): 149-60, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19470301

RESUMO

BACKGROUND: The North American Contact Dermatitis Group (NACDG) tests patients who have suspected allergic contact dermatitis with a broad series of screening allergens, and publishes periodic reports of its data. OBJECTIVE: To report the NACDG patch-test results from January 1, 2005, to December 31, 2006, and to compare results to pooled test data from the previous 10 years. METHODS: Standardized patch testing with 65 allergens was used at 13 centers in North America. Chi-square statistics were utilized for comparisons with previous NACDG data. RESULTS: NACDG patch-tested 4,454 patients; 12.3% (557) had an occupation-related skin condition, and 65.3% (2,907) had at least one allergic patch-test reaction. The 15 most frequently positive allergens were nickel sulfate (19.0%), Myroxilon pereirae (balsam of Peru, 11.9%), fragrance mix I (11.5%), quaternium-15 (10.3%), neomycin (10.0%), bacitracin (9.2%), formaldehyde (9.0%), cobalt chloride (8.4%), methyldibromoglutaronitrile/phenoxyethanol (5.8%), p-phenylenediamine (5.0%), potassium dichromate (4.8%), carba mix (3.9%), thiuram mix (3.9%), diazolidinylurea (3.7%), and 2-bromo-2-nitropropane-1,3-diol (3.4%). As compared to the 1994-2004 data, there were significant increases in rates of positivity to nickel, quaternium-15, potassium dichromate, lidocaine, and tea tree oil. Of patch-tested patients, 22.9% (1,019) had a relevant positive reaction to a supplementary allergen; 4.9% (219) had an occupationally relevant positive reaction to a supplementary allergen. CONCLUSION: Nickel has been the most frequently positive allergen detected by the NACDG; rates significantly increased in the current study period and most reactions were clinically relevant. Other common allergens were topical antibiotics, preservatives, fragrance mix I and paraphenylenediamine. Testing with an expanded allergen series and supplementary allergens enhances detection of relevant positive allergens.


Assuntos
Alérgenos/efeitos adversos , Corantes/efeitos adversos , Cosméticos/efeitos adversos , Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/etiologia , Testes do Emplastro , Conservantes Farmacêuticos/efeitos adversos , Bases de Dados como Assunto , Dermatite Alérgica de Contato/epidemiologia , Humanos , Níquel/efeitos adversos , América do Norte/epidemiologia , Testes do Emplastro/estatística & dados numéricos , Valor Preditivo dos Testes , Prevalência , Medição de Risco/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA